Dow Up0.07% Nasdaq Up0.61%

Vanda Pharmaceuticals, Inc. (VNDA)

-NasdaqGM
12.89 Up 0.20(1.58%) Nov 26, 4:00PM EST
|After Hours : 12.89 0.00 (0.00%) Nov 26, 4:36PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
Total Revenue 14,783   10,862   9,143   8,783  
Cost of Revenue703  198   -   -  
Gross Profit 14,080   10,664   9,143   8,783  
Operating Expenses
Research Development3,702  3,514  7,263  5,957  
Selling General and Administrative11,289  28,139  27,893  9,440  
Non Recurring -   -   -   -  
Others536  617  565  377  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (1,447) (21,606) (26,578) (6,991)
Income from Continuing Operations
Total Other Income/Expenses Net22  31  45  44  
Earnings Before Interest And Taxes(1,425)(21,575)(26,533)(6,947)
Interest Expense -   -   -   -  
Income Before Tax(1,425)(21,575)(26,533)(6,947)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(1,425)(21,575)(26,533)(6,947)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (1,425) (21,575) (26,533) (6,947)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (1,425) (21,575) (26,533) (6,947)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.